TVRD

Tvardi Therapeutics

168 hedge funds and large institutions have $457M invested in Tvardi Therapeutics in 2021 Q3 according to their latest regulatory filings, with 26 funds opening new positions, 50 increasing their positions, 52 reducing their positions, and 29 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more capital invested

Capital invested by funds: $ → $

less ownership

Funds ownership:

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

2% less funds holding

Funds holding: 172168 (-4)

10% less first-time investments, than exits

New positions opened: 26 | Existing positions closed: 29

50% less funds holding in top 10

Funds holding in top 10: 21 (-1)

Holders
168
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$9.38M
Puts
$5.94M
Net Calls
Net Calls Change

Top Buyers

1 +$15.4M
2 +$8.36M
3 +$4.38M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$4.11M
5
Jane Street
Jane Street
New York
+$2.97M
Name Holding Trade Value Shares
Change
Change in
Stake
76
$474K
77
$466K
78
$438K
79
$428K
80
$423K
81
$395K
82
$370K
83
$367K
84
$362K
85
$341K
86
$325K
87
$314K
88
$309K
89
$308K
90
$300K
91
$294K
92
$290K
93
$287K
94
$284K
95
$281K
96
$277K
97
$270K
98
$269K
99
$269K
100
$261K